Zurich Cantonal Bank
BCYC

Zurich Cantonal Bank’s Bicycle Therapeutics BCYC Stock Holding History

Zurich Cantonal Bank’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$100 – 2651
2024
Q1 		$100 Sell
4
-454
-99% -$9.64K ﹤0.01% 2688
2023
Q4 		$8.28K Sell
458
-56
-11% -$927 ﹤0.01% 2679
2023
Q3 		$10.3K Sell
514
-170
-25% -$3.89K ﹤0.01% 2740
2023
Q2 		$17.5K Sell
684
-169
-20% -$3.92K ﹤0.01% 2725
2023
Q1 		$18.1K Buy
853
+458
+116% +$11.5K ﹤0.01% 2770
2022
Q4 		$11.7K Sell
395
-140
-26% -$3.76K ﹤0.01% 2796
2022
Q3 		$12K Hold
535
– – ﹤0.01% 2849
2022
Q2 		$9K Hold
535
– – ﹤0.01% 2860
2022
Q1 		$23K Buy
+535
New +$25K ﹤0.01% 2654

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Zurich Cantonal Bank's BCYC Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of Bicycle Therapeutics (BCYC) in Q2 2024, closing a stake of 4 shares — an estimated $100 sold.

Zurich Cantonal Bank first reported a position in BCYC in Q1 2022 and held it in 9 quarters. The position peaked at $23K in Q1 2022. 107 funds tracked by Wall St. Rank hold BCYC as of Q2 2024.

  • Zurich Cantonal Bank reported no remaining Bicycle Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 4 Bicycle Therapeutics shares in Q2 2024, an estimated $100.
  • Zurich Cantonal Bank first reported a position in Bicycle Therapeutics in Q1 2022 and held it in 9 quarters.
  • Zurich Cantonal Bank's Bicycle Therapeutics position peaked at $23K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.